'Science will lead us out of the pandemic'
Gov. Brown, OHSU partner on research study to inform approach for reopening Oregon
Time at home is the ‘perfect time’ to protect and check your skin
Pediatric resident fears for at-risk, providers who care for them during outbreak
OHSU-led evidence review shows new therapy for Hepatitis C is highly effective
Tim and Mary Boyle give $10 million to OHSU for joint center for biomedical data science
Tom Beer, M.D., F.A.C.P.
Tom Beer, M.D., F.A.C.P., left, deputy director, OHSU Knight Cancer Institute Director, is principal investigator on the PATHFINDER study, which will evaluate the use of an early detection test to identify many types of cancer in a single blood draw. (OHSU/Kristyna Wentz-Graff)
Tom Beer, M.D., F.A.C.P.
Tom Beer, M.D., F.A.C.P., left, deputy director, OHSU Knight Cancer Institute Director, is principal investigator on the PATHFINDER study, which will evaluate the use of an early detection test to identify many types of cancer in a single blood draw. (OHSU/Kristyna Wentz-Graff)
Tom Beer, M.D., F.A.C.P.
Tom Beer, M.D., F.A.C.P., left, deputy director, OHSU Knight Cancer Institute Director, is principal investigator on the PATHFINDER study, which will evaluate the use of an early detection test to identify many types of cancer in a single blood draw. (OHSU/Kristyna Wentz-Graff)
Tom Beer, M.D., F.A.C.P.
Tom Beer, M.D., F.A.C.P., left, deputy director, OHSU Knight Cancer Institute Director, is principal investigator on the PATHFINDER study, which will evaluate the use of an early detection test to identify many types of cancer in a single blood draw. (OHSU/Kristyna Wentz-Graff)
